Regulated Unmasking of the Cryptic Binding Site for Integrin αMβ2 in the γC-Domain of Fibrinogen
The DOI matches its Crossref record.
Abstract
Fibrinogen is a ligand for leukocyte integrin alpha(M)beta2 (CD11b/CD18, Mac-1) and mediates adhesion and migration of leukocytes during the immune-inflammatory responses. The binding site for alpha(M)beta2 resides in gammaC, a constituent subdomain in the D-domain of fibrinogen. The sequence gamma383-395 (P2-C) in gammaC was implicated as the major binding site for alpha(M)beta2. It is unknown why alpha(M)beta2 on leukocytes can bind to immobilized fibrinogen in the presence of high concentrations of soluble fibrinogen in plasma. In this study, we have investigated the accessibility of the binding site in fibrinogen for alpha(M)beta2. We found that the alpha(M)beta2-binding site in gammaC is cryptic and identified the mechanism that regulates its unmasking. Proteolytic removal of the small COOH-terminal segment(s) of gammaC, gamma397/405-411, converted the D100 fragment of fibrinogen, which contains intact gammaC and is not able to inhibit adhesion of the alpha(M)beta2-expressing cells, into the fragment D98, which effectively inhibited cell adhesion. D98, but not D100, bound to the recombinant alpha(M)I-domain, and the alpha(M)I-domain recognition peptide, alpha(M)(Glu253-Arg261). Exposure of the P2-C sequence in fibrinogen, D100, and D98 was probed with a site-specific mAb. P2-C is not accessible in soluble fibrinogen and D100 but becomes exposed in D98. P2-C is also unmasked by immobilization of fibrinogen onto a plastic and by deposition of fibrinogen in the extracellular matrix. Thus, exposure of P2-C by immobilization and by proteolysis correlates with unmasking of the alpha(M)beta2-binding site in the D-domain. These results demonstrate that conformational alterations regulate the alpha(M)beta2-binding site in gammaC and suggest that processes relevant to tissue injury and inflammation are likely to be involved in the activation of the alpha(M)beta2-binding site in fibrinogen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Walkey, C. D., & Chan, W. C. W. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15233e · Cited by 1,758
Fibrinogen and fibrin structure and functions
MOSESSON, M. W. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01365.x · Cited by 1,695
Fibrinogen as a key regulator of inflammation in disease
Davalos, D., & Akassoglou, K. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0290-8 · Cited by 922
Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation
Deng, Z. J., Liang, M., Monteiro, M., Toth, I., & Minchin, R. F. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2010.250 · Cited by 893
Fibrin gels and their clinical and bioengineering applications
Janmey, P. A., Winer, J. P., & Weisel, J. W. (2009) · Journal of The Royal Society Interface · doi:10.1098/rsif.2008.0327 · Cited by 680
Blood–Brain Barrier Pathophysiology in Traumatic Brain Injury
Chodobski, A., Zink, B. J., & Szmydynger-Chodobska, J. (2011) · Translational Stroke Research · doi:10.1007/s12975-011-0125-x · Cited by 650
The multifaceted role of fibrinogen in tissue injury and inflammation
Luyendyk, J. P., Schoenecker, J. G., & Flick, M. J. (2019) · Blood · doi:10.1182/blood-2018-07-818211 · Cited by 555
Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics
Petersen, M. A., Ryu, J. K., & Akassoglou, K. (2018) · Nature reviews. Neuroscience · doi:10.1038/nrn.2018.13 · Cited by 527
Hepatocytes: a key cell type for innate immunity
Zhou, Z., Xu, M.-J., & Gao, B. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.97 · Cited by 472
Flick, M. J., Du, X., Witte, D. P., Jiroušková, M., Soloviev, D. A., Busuttil, S. J., Plow, E. F., & Degen, J. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20741 · Cited by 450
Adams, R. A., Bauer, J., Flick, M. J., Sikorski, S. L., Nuriel, T., Lassmann, H., Degen, J. L., & Akassoglou, K. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061931 · Cited by 335
Ryu, J. K., Petersen, M. A., Murray, S. G., Baeten, K. M., Meyer-Franke, A., Chan, J. P., Vagena, E., Bedard, C., Machado, M. R., Coronado, P. E. R., et al. (2015) · Nature Communications · doi:10.1038/ncomms9164 · Cited by 271
Nanoparticle–protein corona complexes govern the biological fates and functions of nanoparticles
Gunawan, C., Lim, M., Marquis, C. P., & Amal, R. (2014) · Journal of Materials Chemistry B · doi:10.1039/c3tb21526a · Cited by 277
Differential regulation of macrophage inflammatory activation by fibrin and fibrinogen
Hsieh, J. Y., Smith, T. D., Meli, V. S., Tran, T. N., Botvinick, E. L., & Liu, W. F. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.09.024 · Cited by 219
Towards understanding of nanoparticle–protein corona
Ge, C., Tian, J., Zhao, Y., Chen, C., Zhou, R., & Chai, Z. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1458-0 · Cited by 158
Foreign body response to synthetic polymer biomaterials and the role of adaptive immunity
Kyriakides, T. R., Kim, H.-J., Zheng, C., Harkins, L., Tao, W., & Deschenes, E. (2022) · Biomedical Materials · doi:10.1088/1748-605x/ac5574 · Cited by 106
Pereira, R. V. S., EzEldeen, M., Ugarte-Berzal, E., Martens, E., Malengier-Devlies, B., Vandooren, J., Vranckx, J. J., Matthys, P., & Opdenakker, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1170153 · Cited by 48
Metadata
- Authors
- Lishko, V. K., Kudryk, B., Yakubenko, V. P., Yee, V. C., & Ugarova, T. P.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2002-10-01
- Volume
- 41
- Issue
- 43
- Pages
- 12942-12951
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2015332717
- Cited by
- 112
- References
- 0
- FWCI
- 1.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.